NCT02307786View on ClinicalTrials.gov

Long Term Outcomes in β Thalassemia Major

CompletedOBSERVATIONAL
Enrollment

176

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

November 13, 2015

Study Completion Date

November 30, 2016

Conditions
Thalassemia Major
Trial Locations (1)

60611

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

All Listed Sponsors
lead

Ann & Robert H Lurie Children's Hospital of Chicago

OTHER

NCT02307786 - Long Term Outcomes in β Thalassemia Major | Biotech Hunter | Biotech Hunter